26 October 2020

The research group led by researcher and general practitioner Erik Bischoff has received a ZonMw grant from the call ´Goed Gebruik Geneesmiddelen´ for study cardiovascular risk management. 

The grant of over 680,000 euros is intended for research into cardiovascular risk management in people with antipsychotic drugs in general practice. Special is that in addition to this subsidy, the study also receives an in-kind contribution of 130,000 euros from the Arnhem care group Onze Huisartsen BV where the research takes place.
Erik Bischoff: 'The care group has developed a wonderful intervention in which general practitioners, psychiatrists, pharmacists and practice nurses work closely with patients with antipsychotics to reduce unnecessary medication use and reduce the increased risk of cardiovascular disease. In our TACTIC project we will first test this intervention on a small scale and then evaluate its effects and costs in a large experiment'.

Promotion project

The research forms the PhD trajectory for ELG framework doctor for cardiovascular diseases Kirsti Jakobs who played an important role in the development of the intervention. Her earlier research showed that people with severe mental illness (EPA) are estimated to die between eight and twenty years earlier than the general population, especially from cardiovascular diseases.

This ELG study, published in BMC Family Practice, shows that this group is only screened in 8.5%. Only in the case of diabetes mellitus does the annual screening reach 68.4%. People with EPA benefit from a customized cardiovascular risk management (CVRM), but are not yet mentioned in the standard CVRM of the Dutch Society of General Practitioners. Researcher and ELG PhD candidate Kirsti Jakobs: 'Our research also shows that in 68.3% of antipsychotic users no suitable EPA diagnosis was registered in the GP information system. This could be an indication that GPs often prescribe antipsychotics off-label, lack diagnostic information or register the wrong code. GPs are in a key position to proactively invite this vulnerable group to CVRM. It is recommended to be vigilant when prescribing antipsychotics off-label or not properly documented'.

 

Related news items


VWS report on AI and describes added value of MonitAir app

1 February 2022 The report Social costs and benefits of Artificial Intelligence in healthcare from the Dutch Ministry of Health, Welfare and Sport was published. The researchers were positive about the smart app MonitAir, which was partly developed by Primary and Community Care of the Radboudumc. read more

Participating in cancer research among people with intellectual disabilities

30 November 2021 Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer. read more

General practice examines treatment and persistent complaints COVID-19 ZonMw grant for three major projects

3 August 2021 ZonMw has granted a total of 4.3 million euros for research into the treatment of COVID-19 and the symptoms that many people continue to have afterwards (Lung COVID). The research group of the department Primary and Community Care Medicine is co-applicant of these research projects. read more

Henk Schers appointed professor of Regional Network Formation of General Practice

14 July 2021 His research focuses on innovations in the collaboration between healthcare providers from inside and outside the hospital read more

Maarten van der Weijden Foundation selects Radboudumc research for recruitment campaign Preventing cancer in people with intellectual disabilities

1 June 2021 The Maarten van der Weijden Foundation, founded by top swimmer Maarten van der Weijden, supports several innovative cancer research projects each year. One of the three selected this year is Radboudumc's research into the prevention of cancer in people with intellectual disabilities. read more